Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about IRONWOOD PHARMACEUTICALS,
03/10 IRONWOOD PHARMACEUTICALS : to Present at Barclays Global Healthcare Conference
03/09 IRONWOOD PHARMACEUTICALS : Showcases Progress Delivering Innovative Medicines to..
02/28 IRONWOOD PHARMACEUTICALS : to Present at Cowen and Company 37th Annual Health Ca..
02/23 IRONWOOD PHARMACEUTICALS : to Host R&D Day on March 9, 2017
02/21 IRONWOOD PHARMACEUTICALS : reports 4Q loss
02/21 IRONWOOD PHARMACEUTICALS : Provides Fourth Quarter and Full Year 2016 Investor U..
02/07 IRONWOOD PHARMACEUTICALS : to Host Fourth Quarter and Full-Year 2016 Investor Up..
01/30 IRONWOOD PHARMACEUTICALS : Astellas And Ironwood Report Positive Results From Ph..
01/30 IRONWOOD PHARMACEUTICALS : Astellas and Ironwood Report Positive Top-Line Result..
01/26 IRONWOOD PHARMACEUTICALS : U.S. Food and Drug Administration Approves 72 mcg Dos..
01/24 IRONWOOD PHARMACEUTICALS, INC. (NSDQ : IRWD) Has A Near Term Catalyst To Watch
01/09 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Results of Operations ..
01/09 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Termination of a Mater..
01/09 IRONWOOD PHARMACEUTICALS : Demonstrates Strong Execution on Strategy to Build To..
01/06 ACHAOGEN : Appoints Halley Gilbert to Its Board of Directors
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
03/23 IRONWOOD PHARMACEUTICALS : to Present at Barclays Global Healthcare Conference
03/10 IRONWOOD PHARMACEUTICALS : to Present at Barclays Global Healthcare Conference
03/09 IRONWOOD PHARMACEUTICALS : to Present at Cowen and Company 37th Annual Health Ca..
03/09 IRONWOOD PHARMACEUTICALS : Showcases Progress Delivering Innovative Medicines to..
03/02 IRONWOOD PHARMACEUTICALS : to Host R&D Day on March 9, 2017
02/28 IRONWOOD PHARMACEUTICALS : to Present at Cowen and Company 37th Annual Health Ca..
02/23 IRONWOOD PHARMACEUTICALS : to Host R&D Day on March 9, 2017
02/22 IRONWOOD PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
02/21 IRONWOOD PHARMACEUTICALS : reports 4Q loss
02/21 IRONWOOD PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fi..
More news
Sector news : Biotechnology & Medical Research - NEC
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
03/17DJAMGEN : Money-Back Guarantee
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- Update
03/17DJAmgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke
03/14 AstraZeneca ovarian cancer drug slows disease markedly in study
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
03/16 Ironwood Pharmaceuticals (IRWD) Presents At Barclays Global Healthcare Confer..
03/10 Ironwood Pharmaceuticals (IRWD) Host R&D Day
03/07 Ironwood Pharmaceuticals (IRWD) Presents At Cowen and Company 37th Annual Hea..
02/24 SYNERGY : 3 Scenarios, 1 Choice
02/21 Ironwood Pharmaceuticals' (IRWD) CEO Peter Hecht on Q4 2016 Results - Earning..
02/21 Ironwood Pharmaceuticals, Inc. 2016 Q4 - Results - Earnings Call Slides
Latest Tweets
03/16Ironwood Pharmaceuticals (IRWD) Presents At Barclays Global Healthcare Confer.. 
03/16Ironwood Pharmaceuticals (IRWD) Presents At Barclays Global Healthcare Confer.. 
03/15Want the latest upgrades & downgrades for $IRWD $MGRC $ICA $KVHI $HZO? Ch.. 
03/13Ironwood Pharmaceuticals's buy rating reiterated at Mizuho. $21.00 PT.  
03/13Ironwood Pharmaceuticals's buy rating reiterated at BTIG Research. $21.00 PT... 
More tweets
Qtime:15
Advertisement
Financials ($)
Sales 2017 330 M
EBIT 2017 -71,5 M
Net income 2017 -90,7 M
Debt 2017 138 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 8,10x
EV / Sales 2018 6,21x
Capitalization 2 539 M
More Financials
Chart IRONWOOD PHARMACEUTICALS,
Duration : Period :
Ironwood Pharmaceuticals,  Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Full-screen chart
Technical analysis trends IRONWOOD PHARMACE...
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 17,1 $
Spread / Average Target -0,26%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Peter M. Hecht Chief Executive Officer & Director
Terrance G. McGuire Chairman
Thomas Graney Chief Financial Officer & SVP-Corporate Strategy
Mark G. Currie Chief Scientific Officer & Senior Vice President
Brian M. Cali Senior VP-Preclinical, Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
IRONWOOD PHARMACEUTICA..12.30%2 539
INCYTE CORPORATION39.51%28 512
QUINTILES IMS HOLDINGS..3.48%18 567
LONZA GROUP AG3.40%10 684
CELLTRION, INC.--.--%10 016
SEATTLE GENETICS, INC.22.02%9 175
More Results